Senate defeats McCain amendment on Canadian pharmacies

The chamber voted down the amendment, sponsored by Sen. John McCainJohn McCainFox News bests major networks in convention ratings Meghan McCain: ‘I no longer recognize my party’ Why a bill about catfish will show whether Ryan's serious about regulatory reform MORE (R-Ariz.), in a vote of 43-54. The vote had a 60-vote threshold.

Prior to the amendment's defeat McCain blamed the pharmaceutical industry for pressuring the Senate to defeat the legislation.

"In a normal world this would probably require a voice vote, but what we're about to see is the incredible influence of the special interests, particularly pharma, here in Washington, that keeps people who cannot — that have to make a choice between eating and medicine," McCain said. "So what you're about to see is the reason for the cynicism that people have for the way we do things in Washington. Pharma, one of the most powerful lobbies in Washington, will exert its influence again at the expense of average, low income Americans who, again, will have to choose between medication and eating."

The vote came during a series of votes on amendments to a Food and Drug Administration reauthorization bill on Thursday. Thirty Republicans voted against the amendment.

Sen. Charles GrassleyChuck GrassleyTop Dem Senate hopefuls to skip convention Election to shape Supreme Court Why one senator sees Gingrich as Trump's best VP choice MORE (R-Iowa), a long-time supporter of allowing drug importation from Canada, spoke in favor of the McCain language Thursday morning.

"I have always considered drug importation a free-trade issue," Grassley said in his prepared remarks. "Imports create competition and keep domestic industry more responsive to consumers.

"If Americans could legally and safely access prescription drugs outside the United States, then drug companies will be forced to re-evaluate their pricing strategies," he added. "They'd no longer be able to gouge American consumers by making them pay more than their fair share of the high cost of research and development."

A border-state senator, Olympia Snowe (R-Maine), agreed that McCain's amendment would help reduce costs for Americans.

"American consumers are paying 50 percent higher costs for the same prescription drugs than Canadians do," she said. "We know for a fact that allowing drug importation generates considerable cost savings to the government, to individuals and businesses that provide health insurance coverage to their employees."

But Sen. Mike EnziMike EnziSanford-Enzi 'Penny Plan' gets nation to a balanced budget Majority of GOP senators to attend Trump convention Judd Gregg: The silver lining MORE (R-Wyo.) argued that the amendment would put the safety of Americans at risk, since it would let Canadian Internet pharmacies sell into the United States without any of the approval processes applied to U.S. drugs. "We're not talking about bus trips of seniors to reputable pharmacies right across the border," Enzi said.

Enzi added that drugs from Canada would actually be from anywhere around the world, as Canadian pharmacies have acknowledged that they get most of their drugs from overseas.

"Drugs that supposedly come from Canada can really come from any place in the world and then are shipped from Canada," he said.

Shortly after the McCain amendment's defeat, the Senate defeated one sponsored by Sen. Bernie SandersBernie SandersSanders delegates search for funding Trump slams Clinton's VP pick: 'I was shocked' Biden to end long career by boosting his rival MORE (I-Vt.) which takes away a drug company's exclusive marketing rights if that company is found guilty of fraud. The Senate defeated Sanders's bill 9 to 88.

The Senate also tabled an amendment by Sen. Dick DurbinDick DurbinOpioid package clears key Senate hurdle Overnight Healthcare: Feds defend ObamaCare's affordability DNC chief spared in Sanders-Clinton talks: report MORE (D-Ill.) which would have established a requirement that dietary supplement manufacturers to register with the FDA. 

—This story was updated at 3:14 p.m.

More in Senate

Senate GOP vulnerables skipping Trump meeting

Read more »